A Review of the Evidence for Using Bedaq
โ
Gregory J. Fox, Dick Menzies
๐
Article
๐
2013
๐
Springer Healthcare Communications
๐
English
โ 600 KB
Existing therapies for multi-drug resistant tuberculosis (MDR-TB) have substantial limitations, in terms of their effectiveness, side-effect profile, and complexity of administration. Bedaquiline is a novel diarylquinoline antibiotic that has recently been investigated as an adjunct to existing ther